BEE RX Trademark

Trademark Overview

On Monday, August 17, 2020, a trademark application was filed for BEE RX with the United States Patent and Trademark Office. The USPTO has given the BEE RX trademark a serial number of 90118353. The federal status of this trademark filing is REGISTERED as of Tuesday, January 2, 2024. This trademark is owned by Taro Pharmaceuticals U.S.A., Inc.. The BEE RX trademark is filed in the Pharmaceutical Products category with the following description:

Analgesics; topical analgesics, namely, preparations for the relief of pain, joint stiffness and muscular discomfort; Medicinal preparations, namely, topical treatments, for the treatment of rosacea, acne, actinic keratosis, skin irritation, redness, inflammation; medicated masks for the treatment of rosacea, acne, actinic keratosis, redness, inflammation; Medicinal preparations for the treatment of blisters, cuts, burns and other minor wounds; medicinal preparations for the treatment of cold sores, blisters and other minor wounds; antibacterial preparations for the treatment of cold sores, blisters and other minor wounds; antimicrobial preparations for the treatment of cold sores, blisters and other minor wounds
bee rx

General Information

Serial Number90118353
Word MarkBEE RX
Filing DateMonday, August 17, 2020
Status700 - REGISTERED
Status DateTuesday, January 2, 2024
Registration Number7262501
Registration DateTuesday, January 2, 2024
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 22, 2020

Trademark Statements

Description of MarkThe mark consists of the words "BEE RX" beneath a bee.
Goods and ServicesAnalgesics; topical analgesics, namely, preparations for the relief of pain, joint stiffness and muscular discomfort; Medicinal preparations, namely, topical treatments, for the treatment of rosacea, acne, actinic keratosis, skin irritation, redness, inflammation; medicated masks for the treatment of rosacea, acne, actinic keratosis, redness, inflammation; Medicinal preparations for the treatment of blisters, cuts, burns and other minor wounds; medicinal preparations for the treatment of cold sores, blisters and other minor wounds; antibacterial preparations for the treatment of cold sores, blisters and other minor wounds; antimicrobial preparations for the treatment of cold sores, blisters and other minor wounds
Disclaimer with Predetermined Text"RX"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 18, 2020
Primary Code005
First Use Anywhere DateWednesday, March 31, 2021
First Use In Commerce DateWednesday, March 31, 2021

Trademark Owner History

Party NameTaro Pharmaceuticals U.S.A., Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressHawthorne, NY 10532
Party NameTaro Pharmaceuticals U.S.A., Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHawthorne, NY 10532
Party NameTaro Pharmaceuticals U.S.A., Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHawthorne, NY 10532

Trademark Events

Event DateEvent Description
Tuesday, January 2, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 2, 2024REGISTERED-PRINCIPAL REGISTER
Friday, December 1, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, November 30, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, October 31, 2023STATEMENT OF USE PROCESSING COMPLETE
Monday, October 23, 2023USE AMENDMENT FILED
Monday, October 23, 2023TEAS STATEMENT OF USE RECEIVED
Saturday, August 19, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 18, 2023SOU EXTENSION 5 GRANTED
Friday, August 11, 2023SOU EXTENSION 5 FILED
Friday, August 18, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, August 11, 2023SOU TEAS EXTENSION RECEIVED
Friday, February 17, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 15, 2023SOU EXTENSION 4 GRANTED
Wednesday, February 15, 2023SOU EXTENSION 4 FILED
Wednesday, February 15, 2023SOU TEAS EXTENSION RECEIVED
Thursday, August 18, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 16, 2022SOU EXTENSION 3 GRANTED
Tuesday, August 16, 2022SOU EXTENSION 3 FILED
Tuesday, August 16, 2022SOU TEAS EXTENSION RECEIVED
Friday, February 18, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 16, 2022SOU EXTENSION 2 GRANTED
Wednesday, February 16, 2022SOU EXTENSION 2 FILED
Wednesday, February 16, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, August 18, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 16, 2021SOU EXTENSION 1 GRANTED
Monday, August 16, 2021SOU EXTENSION 1 FILED
Monday, August 16, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, February 16, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 22, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 22, 2020PUBLISHED FOR OPPOSITION
Wednesday, December 2, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 17, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 17, 2020EXAMINER'S AMENDMENT ENTERED
Tuesday, November 17, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, November 17, 2020EXAMINERS AMENDMENT E-MAILED
Tuesday, November 17, 2020EXAMINERS AMENDMENT -WRITTEN
Monday, November 16, 2020ASSIGNED TO EXAMINER
Saturday, September 19, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, September 18, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 20, 2020NEW APPLICATION ENTERED

Related Keywords

preparations treatment minor blisters other wounds medicinal sores cold actinic